Entering text into the input field will update the search result below

F-star Therapeutics surges as buyer Sino Biopharma gains CFIUS approval

Mar. 07, 2023 9:10 AM ETF-star Therapeutics, Inc. (FSTX), SBHMYBy: Joshua Fineman, SA News Editor3 Comments

word m and a made with wood building blocks, stock image

Maksim Labkouski/iStock via Getty Images

F-star Therapeutics (NASDAQ:FSTX) jumped 16% in premarket trading after its sale to Sino Biopharmaceuticals (OTCPK:SBHMY) won approval from the Committee on Foreign Investment in the U.S.

CFIUS clearance is the final regulatory approval needed to complete the

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.